The identification of novel somatic variants, particularly in genes like ARID1A and MLH1, which play critical roles in chromatin remodeling and DNA mismatch repair, respectively, further emphasizes the need for personalized approaches in cancer treatment. Here, MLH1 is linked to cancer.